| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| olanzapine | Tablet, orally disintegrating | 5 mg | Anticipated | Available | Manufacturing | 9/05/2025 |
| paclitaxel | Injection, concentrated | 300 mg | Resolved | Available | Manufacturing | 9/05/2025 |
| hydrocortisone | Tablet, uncoated | 20 mg | Current | Limited Availability | Manufacturing | 9/05/2025 |
| hydrocortisone | Tablet, uncoated | 20 mg | Current | Limited Availability | Manufacturing | 9/05/2025 |
| spironolactone | Tablet, uncoated | 25 mg | Current | Limited Availability | Manufacturing | 9/05/2025 |
| terbinafine hydrochloride | Tablet, uncoated | 281.25 mg | Anticipated | Available | Manufacturing | 8/05/2025 |
| prazosin hydrochloride | Tablet, uncoated | 2.19 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 8/05/2025 |
| sumatriptan succinate | Tablet, film coated | 140 mg | Current | Unavailable | Manufacturing | 8/05/2025 |
| risperidone | Tablet, film coated | 2 mg | Current | Unavailable | Manufacturing | 8/05/2025 |
| midazolam | Injection, solution | 5 mg/mL | Current | Unavailable | Manufacturing | 8/05/2025 |
| midazolam | Injection, solution | 1 mg/mL | Current | Limited Availability | Manufacturing | 8/05/2025 |
| olanzapine | Tablet, film coated | 5 mg | Anticipated | Available | Manufacturing | 8/05/2025 |
| gabapentin | Tablet, film coated | 800 mg | Discontinued | Unavailable | Manufacturing | 8/05/2025 |
| galantamine hydrobromide | Capsule, modified release | 20.512 mg | Anticipated | Available | Manufacturing | 8/05/2025 |
| midazolam | Injection, solution | 5 mg | Current | Limited Availability | Manufacturing | 8/05/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.9 mg | Current | Limited Availability | Manufacturing | 8/05/2025 |
| acetylcysteine | Injection, concentrated | 2 g | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 8/05/2025 |
| lansoprazole | Tablet, orally disintegrating | 15 mg | Current | Limited Availability | Manufacturing | 8/05/2025 |
| quetiapine fumarate | Tablet, film coated | 28.784 mg | Current | Limited Availability | Unexpected increase in consumer demand | 8/05/2025 |
| simvastatin~ezetimibe | Tablet | 10 mg~10 mg | Anticipated | Available | Manufacturing | 8/05/2025 |
| simvastatin~ezetimibe | Tablet | 20 mg~10 mg | Anticipated | Available | Manufacturing | 8/05/2025 |
| celecoxib | Capsule, hard | 200 mg | Current | Limited Availability | Manufacturing | 8/05/2025 |
| nicorandil | Tablet | 20 mg | Anticipated | Available | Manufacturing | 8/05/2025 |
| nicorandil | Tablet | 10 mg | Current | Unavailable | Manufacturing | 8/05/2025 |
| atomoxetine hydrochloride | Capsule, hard | 91.44 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 8/05/2025 |
| noradrenaline (norepinephrine) acid tartrate monohydrate | Injection, concentrated | 2 mg/mL | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 8/05/2025 |
| dexmedetomidine hydrochloride | Injection, concentrated | 118 microgram/mL | Current | Unavailable | Manufacturing | 8/05/2025 |
| dexmedetomidine hydrochloride | Injection, intravenous infusion | 118 microgram/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 8/05/2025 |
| escitalopram oxalate | Tablet, film coated | 12.74 mg | Current | Limited Availability | Commercial Changes / Commercial viability | 8/05/2025 |
| solifenacin succinate | Tablet, film coated | 10 mg | Current | Unavailable | Manufacturing | 8/05/2025 |
| codeine phosphate hemihydrate~ibuprofen | Tablet, film coated | 12.8 mg~200 mg | Resolved | Available | Manufacturing | 8/05/2025 |
| emtricitabine~tenofovir disoproxil fumarate | Tablet, film coated | 200 mg~300 mg | Resolved | Available | Manufacturing | 8/05/2025 |
| deferasirox | Tablet, film coated | 90 mg | Anticipated | Available | Manufacturing | 8/05/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 86.751 mg | Current | Limited Availability | Manufacturing | 8/05/2025 |
| rivaroxaban | Tablet, film coated | 20 mg | Current | Unavailable | Manufacturing | 8/05/2025 |
| spironolactone | Tablet, uncoated | 100 mg | Current | Limited Availability | Manufacturing | 8/05/2025 |
| metoprolol tartrate | Tablet, uncoated | 50 mg | Anticipated | Available | Manufacturing | 8/05/2025 |
| dutasteride~tamsulosin hydrochloride | Capsule, modified release | 500 microgram~400 microgram | Resolved | Available | Manufacturing | 8/05/2025 |
| gemfibrozil | Tablet, film coated | 600 mg | Current | Unavailable | Manufacturing | 8/05/2025 |
| primidone | Tablet, uncoated | 250 mg | Current | Unavailable | Manufacturing | 7/05/2025 |
| bupivacaine hydrochloride monohydrate | Injection, solution | 52.7 mg | Current | Limited Availability | Unexpected increase in consumer demand | 7/05/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 7/05/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.9 mg | Current | Unavailable | Unexpected increase in consumer demand | 7/05/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Current | Limited Availability | Unexpected increase in consumer demand | 7/05/2025 |
| ezetimibe~rosuvastatin calcium | Tablet~Tablet, film coated | 10 mg~10.396 mg | Current | Unavailable | Manufacturing | 7/05/2025 |
| cisplatin | Injection, solution | 1 mg/mL | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 7/05/2025 |
| erythromycin | Capsule, enteric | 250 mg | Current | Limited Availability | Commercial Changes / Commercial viability | 7/05/2025 |
| spironolactone | Tablet, film coated | 25 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 7/05/2025 |
| midazolam | Injection, solution | 1 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 7/05/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 7/05/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 7/05/2025 |
| betiatide | Injection, powder for | 1 mg | Current | Unavailable | Manufacturing | 6/05/2025 |
| flecainide acetate | Injection, solution | 10 mg/mL | Current | Unavailable | Manufacturing | 6/05/2025 |
| propofol | Injection, emulsion | 10 g/L | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 6/05/2025 |
| tramadol hydrochloride | Tablet, modified release | 200 mg | Current | Limited Availability | Manufacturing | 6/05/2025 |
| carbidopa monohydrate~levodopa~entacapone | Tablet, film coated | 27 mg~100 mg~200 mg | Anticipated | Available | Manufacturing | 6/05/2025 |
| rosuvastatin calcium~ezetimibe | Tablet~Tablet, film coated | 41.583 mg~10 mg | Current | Limited Availability | Manufacturing | 6/05/2025 |
| Follitropin alfa | Injection, solution | 75 IU | Resolved | Available | Manufacturing | 6/05/2025 |
| imatinib mesilate | Tablet, film coated | 119.5 mg | Current | Unavailable | Unexpected increase in consumer demand | 6/05/2025 |
| cisplatin | Injection, concentrated | 1 mg/mL | Resolved | Available | Manufacturing | 6/05/2025 |
| lacosamide | Tablet, film coated | 200 mg | Current | Limited Availability | Manufacturing | 6/05/2025 |
| dimethyl fumarate | Capsule, enteric | 120 mg | Current | Unavailable | Manufacturing | 6/05/2025 |
| lurasidone hydrochloride | Tablet, film coated | 80 mg | Current | Unavailable | Manufacturing | 6/05/2025 |
| sitagliptin hydrochloride monohydrate | Tablet, film coated | 109 mg | Resolved | Available | Manufacturing | 6/05/2025 |
| sitagliptin hydrochloride monohydrate | Tablet, film coated | 54.5 mg | Current | Unavailable | Manufacturing | 6/05/2025 |
| levothyroxine sodium | Tablet, uncoated | .075 mg | Current | Limited Availability | Manufacturing | 6/05/2025 |
| levothyroxine sodium | Tablet, uncoated | .1 mg | Current | Limited Availability | Manufacturing | 6/05/2025 |
| rivaroxaban | Tablet, film coated | 2.5 mg | Current | Unavailable | Unexpected increase in consumer demand | 6/05/2025 |
| rivaroxaban | Tablet, film coated | 10 mg | Current | Unavailable | Unexpected increase in consumer demand | 6/05/2025 |
| sodium chloride | Injection, intravenous infusion | 900 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 6/05/2025 |
| cabergoline | Tablet, uncoated | 1 mg | Anticipated | Available | Manufacturing | 6/05/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 873.32 mg | Anticipated | Available | Manufacturing | 6/05/2025 |
| prazosin hydrochloride | Tablet, uncoated | 1.095 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 5/05/2025 |
| trandolapril | Capsule | 4 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 5/05/2025 |
| sodium pyrophosphate | Injection, powder for | 30 mg | Current | Unavailable | Manufacturing | 5/05/2025 |
| fludarabine phosphate | Injection, powder for | 50 mg | Anticipated | Available | Manufacturing | 5/05/2025 |
| octreotide | Injection, solution | 100 microgram | Current | Limited Availability | Manufacturing | 5/05/2025 |
| octreotide | Injection, solution | 500 microgram | Current | Unavailable | Manufacturing | 5/05/2025 |
| octreotide | Injection, solution | 50 microgram | Current | Limited Availability | Manufacturing | 5/05/2025 |
| morphine hydrochloride trihydrate | Oral Liquid, solution | 10 mg/mL | Resolved | Available | Commercial Changes / Commercial viability | 5/05/2025 |
| mycophenolate mofetil | Capsule | 250 mg | Anticipated | Available | Manufacturing | 5/05/2025 |
| levetiracetam | Tablet, film coated | 500 mg | Anticipated | Available | Manufacturing | 5/05/2025 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Anticipated | Available | Unexpected increase in consumer demand | 5/05/2025 |
| montelukast sodium | Tablet, film coated | 10.4 mg | Anticipated | Available | Manufacturing | 5/05/2025 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Anticipated | Available | Manufacturing | 5/05/2025 |
| bicalutamide | Tablet, film coated | 50 mg | Current | Unavailable | Manufacturing | 5/05/2025 |
| methotrexate | Injection, solution | 100 mg/mL | Current | Unavailable | Manufacturing | 5/05/2025 |
| rifampicin | Capsule | 300 mg | Anticipated | Available | Manufacturing | 5/05/2025 |
| amiodarone hydrochloride | Injection, solution | 150 mg | Resolved | Available | Manufacturing | 5/05/2025 |
| live varicella vaccine | Injection, powder for | 4000 PFU/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 5/05/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Manufacturing | 5/05/2025 |
| acamprosate calcium | Tablet, enteric coated | 333 mg | Current | Limited Availability | Manufacturing | 5/05/2025 |
| isavuconazonium sulfate | Capsule, hard | 186.3 mg | Current | Limited Availability | Manufacturing | 5/05/2025 |
| midodrine hydrochloride | Tablet | 5 mg | Anticipated | Available | Manufacturing | 5/05/2025 |
| naloxone hydrochloride dihydrate | Spray, nasal | 2.2 mg/actuation | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 5/05/2025 |
| nebivolol hydrochloride | Tablet | 10.9 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 5/05/2025 |
| prazosin hydrochloride | Tablet, uncoated | 1.1 mg | Current | Unavailable | Manufacturing | 5/05/2025 |
| prazosin hydrochloride | Tablet, uncoated | 2.2 mg | Current | Unavailable | Manufacturing | 5/05/2025 |
| reboxetine mesilate | Tablet, uncoated | 5.224 mg | Current | Unavailable | Manufacturing | 5/05/2025 |
2025年5月12日